- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-02-0015163

About Therdose Pharma Private Limited
Data last updated:
Therdose Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Vance And Health Pharmaceuticals Private Limited. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 19 December 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2003PTC042272. Its GSTIN is 36AAACO6469N1ZT (Telangana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹9.99 Cr. It was formerly known as Oshadha Therapeutics Private Limited. It is led by directors including Ratna Sekhar Rao Imadabathuni (Managing Director) and Mahindra Dev Imadabathuni (Whole-Time Director).
Its last annual general meeting (AGM) was held on 29 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹26.66 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net loss of ₹4.9 Cr (net margin -18.4%) and EBITDA of -₹1.89 Cr (EBITDA margin -7.1%). Revenue has grown at a compounded annual rate (CAGR) of 4% over five years.
The company has about 150 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: TherDose. As per MCA filings, the company has open charges of ₹11.58 Cr and satisfied charges of ₹24.13 Cr on record. Court records list 25 cases involving the company, including 9 filed by the company and 16 filed against it; 12 cases are pending. The company has 7 deals on record (4 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹36.46 Cr; the latest was in November 2021.
Therdose Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0015163). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website therdose.com.
Company details
CIN history
Therdose Pharma has one previous CIN (Corporate Identification Number): U24239AP2003PTC042272. The current CIN is U24239TG2003PTC042272, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2003PTC042272 | Current |
| U24239AP2003PTC042272 | Previous |
Recognitions & Rankings of Therdose Pharma
Contact details
Therdose Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is therdose.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No.118 119 & 120 Survey No.342 Aleap Industrialestate Opp:Jntu Pragati Nagar, Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryPharma, Pharma Contract R&D, Drug Formulation & Development
To see the full contact details of Therdose Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Therdose Pharma operates one associated brand: TherDose. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Oncology-focused generic and specialty drugs are developed and manufactured. | therdose.com |
Business activity
The main business activity of Therdose Pharma is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Therdose Pharma Private Limited, buy the company report.
Financials of Therdose Pharma Private Limited
FY 2024 filings availableTherdose Pharma Private Limited reported revenue of ₹26.66 Cr (up 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 12% growth in the latest year. EBITDA fell 197% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.89 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.9 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -7.1% | ||||
| Net Profit Margin | -18.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Therdose Pharma Private Limited, buy the company report.
Board of directors of Therdose Pharma Private Limited
Therdose Pharma has 7 current directors and 16 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Meka Kesava Sambasiva Rao Also directs: DHS Hotels Private Limited | Director | 26 Nov 2021 | 4 Years 11 Months | Current |
| Narayana Raju Mantana Also directs: Vance and Health Pharmaceuticals Private Limited | Director | 15 Apr 2024 | 2 Years 7 Months | Current |
| Arvind Reddy Panyala Also directs: Vance and Health Pharmaceuticals Private Limited | Director | 26 Nov 2021 | 4 Years 11 Months | Current |
| Mahindra Dev Imadabathuni Also directs: Vance and Health Pharmaceuticals Private Limited | Whole-Time Director | 26 Nov 2021 | 4 Years 11 Months | Current |
| Raja Vakula Devi Imadabathuni Also directs: Vance and Health Pharmaceuticals Private Limited | Director | 03 Oct 2022 | 4 Years 1 Months | Current |
| Ratna Sekhar Rao Imadabathuni Also directs: Vance and Health Pharmaceuticals Private Limited | Managing Director | 12 Nov 2021 | 5 Years 0 Months | Current |
Auditor
Therdose Pharma Private Limited is audited by R B ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R B ASSOCIATES | FY 2023 | 009112S |
Shareholding
The shareholding of Therdose Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Therdose Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Dec 2022 | 100660592 | Others | ₹11.58 Cr | Open | |
| 06 May 2022 | 100577114 | Axis Bank Limited | ₹25.68 Lakh | Satisfied | |
| 31 Jul 2018 | 100266341 | Others | ₹58.75 Lakh | Satisfied | |
| 31 Jul 2015 | 10585321 | Reliance Capital Ltd | ₹74 Lakh | Satisfied | |
| 21 Mar 2012 | 10354617 | Others | ₹12.65 Cr | Satisfied |
To see the full charge records of Therdose Pharma Private Limited, buy the company report.
Total charge records: 7 View all charges
Deals & funding
Therdose Pharma Private Limited has 7 deals on record (4 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹36.46 Cr; the latest was in November 2021.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2021 | Funding round | ₹9.99 Cr | Investors: Vance and Health Pharmaceuticals Private Limited , an individual |
| Sep 2016 | Funding round | ₹26.47 Cr | Investors: Hitha Palepu Irrevocable Stock Trust of 2010, Robert Pragada Irrevocable Stock Trust of 2010 |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Scidose LLC |
| Sep 2014 | Rights issue | ₹19.1 Lakh | Investors: 2 individuals |
| Nov 2008 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of Therdose Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Therdose Pharma Private Limited has 25 court cases on record: 9 filed by Therdose Pharma, 16 filed against it. 12 cases are pending and 13 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 11 | 11 | 3 |
| High courts | 9 | 0 | 8 |
| NCLAT | 4 | 4 | 1 |
| NCLT | 1 | 1 | 0 |
Cases on record (5 of 25)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Magma Fincorp Limited | Pending |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Neogrowth Credit Pvt. Ltd. | Disposed |
| District court, Hyderabad Central, Telangana | Criminal complaint | Filed against the company by HDFC Bank Ltd. Rep by Mr.Syed Shafiuddin | Disposed |
| High Court for State of Telangana | Writ petition | Filed by the company against State of Telangana | Pending |
| High Court for State of Telangana | Writ petition | Filed by the company against State of Telangana, | Pending |
To see the full case history of Therdose Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Therdose Pharma Private Limited was last rated by Icra on 16 Jun 2022.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 16 Jun 2022 |
To see the full credit ratings and regulatory alerts of Therdose Pharma Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Therdose Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Therdose Pharma Private Limited has a workforce of 150 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 150 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Therdose Pharma Private Limited, buy the company report.
GST
Therdose Pharma has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACO6469N1ZT | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Therdose Pharma Private Limited, buy the company report.
Recent activity
Therdose Pharma Private Limited has 23 board changes on record since 2008: 8 appointments and 15 cessations. The latest: Narayana Raju Mantana ceased to be Additional Director on 28 Sep 2024.
31 earlier events are in the company report.
Frequently asked questions
Therdose Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 19 December 2003 (23+ years old) and is registered under CIN U24239TG2003PTC042272.
Therdose Pharma has 7 current directors:
- Ratna Sekhar Rao Imadabathuni - Managing Director
- Mahindra Dev Imadabathuni - Whole-Time Director
- Meka Kesava Sambasiva Rao - Director
- Narayana Raju Mantana - Director
- Arvind Reddy Panyala - Director
- Raja Vakula Devi Imadabathuni - Director
- Mantena Raju Narasa - Director
The latest financial statements of Therdose Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 29 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Therdose Pharma is 36AAACO6469N1ZT, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Therdose Pharma is U24239TG2003PTC042272. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Therdose Pharma has 25 court cases on record: 9 filed by the company and 16 filed against it. 12 are pending. Most are in the district courts.
Therdose Pharma was incorporated on 19 December 2003, making it 23+ years old. It is registered with the Registrar of Companies, Hyderabad.
Therdose Pharma has 7 deals on record (4 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹36.46 Cr; the latest was in November 2021.
Narayana Raju Mantana ceased to be Additional Director on 28 Sep 2024. Narayana Raju Mantana was appointed as Director on 15 Apr 2024. Raja Vakula Devi Imadabathuni ceased to be Additional Director on 28 Sep 2023. Therdose Pharma has 23 board changes on record in total.
Yes, Therdose Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0015163).

